A need to blend pharmacoepidemiology and pharmacoeconomics Carlene Todd Newsletter Article 16 February 2013 Pages: 3 - 4
An economic argument for home IV antibacterial therapy Newsletter Article 16 February 2013 Pages: 5 - 5
German primary care physicians find drug formulary helpful Newsletter Article 16 February 2013 Pages: 6 - 6
Cost analysis of antineoplastic-induced neutropenia Newsletter Article 16 February 2013 Pages: 10 - 10
Standardised HSV prophylaxis protocol leads to cost savings Newsletter Article 16 February 2013 Pages: 11 - 11
Filgrastim cost effective in antineoplastic-induced neutropenia Newsletter Article 16 February 2013 Pages: 11 - 11
NHS prescribing rapidly shifting to privatisation? Newsletter Article 16 February 2013 Pages: 15 - 15
Psychotropic costs shifted during US capping programme Newsletter Article 16 February 2013 Pages: 16 - 16